Nanotechnology Promotes Genetic and Functional Modifications of Therapeutic T Cells Against Cancer-Reference-Cited by-同舟云学术

Nanotechnology Promotes Genetic and Functional Modifications of Therapeutic T Cells Against Cancer

Published:2020-02-20 Issue:10 Volume:7 Page:1903164
ISSN:2198-3844
Container-title:Advanced Science
language:en
Short-container-title:Adv. Sci.

Author:

Abdalla Ahmed M. E.¹²,Xiao Lin¹,Miao Yu³,Huang Lixia⁴,Fadlallah Gendeal M.⁵,Gauthier Mario⁶,Ouyang Chenxi⁷,Yang Guang¹^ORCID

Affiliation:

1. Department of Biomedical EngineeringCollege of Life Science and TechnologyHuazhong University of Science and Technology Wuhan 430074 China

2. Department of BiochemistryCollege of Applied ScienceUniversity of Bahri Khartoum 1660/11111 Sudan

3. Department of Vascular SurgeryGeneral Hospital of Ningxia Medical University Yinchuan 750004 China

4. Hubei Key Laboratory of Purification and Application of Plant Anti‐Cancer Active IngredientsSchool of Chemistry and Life SciencesHubei University of Education Wuhan 430205 China

5. Department of Chemistry and BiologyFaculty of EducationUniversity of Gezira Wad‐Medani 2667 Sudan

6. Department of ChemistryUniversity of Waterloo Waterloo N2L 3G1 Canada

7. Department of Vascular SurgeryFuwai HospitalNational Center for Cardiovascular DiseaseChinese Academy of Medical Sciences and Peking Union Medical College Beijing 100037 China

Funder

National Basic Research Program of China

National Natural Science Foundation of China

China Postdoctoral Science Foundation

Publisher

Wiley

Subject

General Physics and Astronomy,General Engineering,Biochemistry, Genetics and Molecular Biology (miscellaneous),General Materials Science,General Chemical Engineering,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/advs.201903164

Reference147 articles.

1. Clinical Cancer Advances 2018: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology

2. CAR T cell immunotherapy for human cancer

3. Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia

4. Phase 1 Results of ZUMA-1: A Multicenter Study of KTE-C19 Anti-CD19 CAR T Cell Therapy in Refractory Aggressive Lymphoma

5. Recent advances in T-cell immunotherapy for haematological malignancies

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bioactive-material-programmed CAR-T cell living drug for augmented immunotherapy against tumors;Cell Reports Physical Science;2024-06

2. Anti-tumor immune potentiation targets-engineered nanobiotechnologies: Design principles and applications;Progress in Materials Science;2024-04

3. CAR‐T cell therapeutic avenue for fighting cardiac fibrosis: Roadblocks and perspectives;Cell Biochemistry and Function;2024-02-20

4. The quest for nanoparticle-powered vaccines in cancer immunotherapy;Journal of Nanobiotechnology;2024-02-14

5. Enhancing drug penetration in solid tumors via nanomedicine: Evaluation models, strategies and perspectives;Bioactive Materials;2024-02